Reimagine growth at Elevate – Dallas 2025. See the Agenda.
Filter
Displaying 11-20 of 32 for "Outsourcing"
Five Factors Transforming the Life Sciences Supply Chain and Creating IT Opportunities | Blog
Supply chain visibility, strategic sourcing, cold chain requirements, sustainability demands, and personalized medicine are creating opportunities in the life sciences supply chain for IT partners delivering digital solutions. Read this first part of our blog series to understand the shift […]
Increased Deal Activity in Revenue Cycle Management (RCM): What is the Winning Formula? | Blog
Health systems are increasingly seeking competitive proposals post-pandemic to outsource Revenue Cycle Management (RCM) and get the best prices and innovation in contracts. Learn what enterprises want and how providers can win these RFPs. Why has outsourcing gained traction in […]
“It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change.” – Charles Darwin Charles Darwin’s famous words aptly describe what healthcare payers need to do in the times of […]
It should come as no surprise that global services activity in the U.K. has dropped significantly in all sectors in the aftermath of the Brexit referendum. Indeed, according to our Transaction Intelligence database of sourcing deals, in the healthcare space, […]
Pharma Service Providers’ Role in Tempering Pricing Wars | Sherpas in Blue Shirts
Shortly after the U.S. Food & Drug Administration (FDA) approved Novartis’ CAR T-cell drug, Kymriah – which is used for pediatric B-cell Acute Lymphoblastic Leukemia – last month, Novartis announced its price…a whopping $475,000 per patient. This is certainly not […]
Technology is the Key to Innovation in Pharmacovigilance | Sherpas in Blue Shirts
The critical nature of Pharmacovigilance (PV) is obvious. For patients, it can mean the difference between better health or death from an Adverse Drug Reaction (ADR). For pharma companies, it can mean the difference between a profitable, life-saving drug, or multi-billion […]
The Wide-Ranging Impacts of a Single Payer Healthcare System | Sherpas in Blue Shirts
On June 1, 2017, the California state senate passed the “Healthy California Act (HCA.)” The bill (SB 562), which is now in the state assembly for further action, aims to replace all private/government insurance plans in the state with a […]
What Pain will You Experience if the AHCA Bill Becomes Law? | Sherpas in Blue Shirts
Health insurance lost for 24 million U.S. consumers Billions of dollars of care investment marginalized Providers’ margins eroded by payers And a five-year setback to the healthcare system These are potential side effects if the U.S. House of Representatives- approved […]
The Battle over Healthcare: Round One Ends with a Whimper and Uncertainty | Sherpas in Blue Shirts
Healthcare reform has become a political slugfest, casting a spell of ambiguity as the world’s largest healthcare economy attempts to fundamentally transform itself. Consequently, the global services industry is waiting with baited breath to see how this upheaval pans out. […]
Pharma BPO: What Justifies Premium Resource Pricing? | Sherpas in Blue Shirts
The global pharma industry, hit hard by the rise of generics and the patent cliff on branded drugs, has been in cost-cutting mode, especially since the beginning of this decade. With the rising costs of R&D and new drug development, […]